Inspire Medical Systems (INSP) Stock Price
Inspire Medical Systems Price
Inspire Medical Systems (INSP) Stock | ISIN US4577301090 | WKN A2JLEP. The current Inspire Medical Systems stock price is 42.66 USD (2026). Revenue is 991.28 M USD. Net income is 51.23 M USD. The P/E ratio is 24.78. Market capitalization is 1.24 B USD. Inspire Medical Systems operates in the Health sector.
Inspire Medical Systems stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Inspire Medical Systems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Inspire Medical Systems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Inspire Medical Systems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Inspire Medical Systems Price |
|---|
Inspire Medical Systems Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Inspire Medical Systems Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Inspire Medical Systems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Inspire Medical Systems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Inspire Medical Systems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Inspire Medical Systems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Inspire Medical Systems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Inspire Medical Systems stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Inspire Medical Systems Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Inspire Medical Systems business model & stock analysis
Inspire Medical Systems SWOT Analysis
Strengths
Inspire Medical Systems Inc possesses several strengths that contribute to its success and competitive advantage in the market:
- Innovative and patented technology
- Highly effective treatment for obstructive sleep apnea
- Significant reduction in healthcare costs through long-term treatment benefits
- Strong relationships with healthcare professionals and key opinion leaders
- Robust sales and distribution network
Weaknesses
Despite its strengths, Inspire Medical Systems Inc faces certain weaknesses that it should address to maintain its market position:
- Relatively high cost of treatment compared to alternative therapies
- Dependency on reimbursement policies and insurance coverage
- Limited market penetration in certain geographic regions
- Requires a surgical procedure for permanent implantation
- Need for ongoing patient compliance and follow-up
Opportunities
There are several opportunities that Inspire Medical Systems Inc can capitalize on to drive growth and expand its market presence:
- Increasing prevalence of obstructive sleep apnea globally
- Emerging markets with untapped potential for sleep apnea treatment
- Technological advancements improving the efficacy and affordability of treatment
- Partnerships with healthcare providers to enhance awareness and adoption
- Expanding product portfolio to address related sleep disorders
Threats
Inspire Medical Systems Inc faces certain threats that may hinder its growth and competitive position:
- Intense competition from alternative therapies and medical devices
- Regulatory challenges and compliance requirements
- Economic uncertainties impacting healthcare spending
- Shifts in reimbursement policies and insurance coverage
- Potential side effects or complications associated with the treatment
Inspire Medical Systems Segments
Inspire Medical Systems Revenue by Segment
Max
Details
Inspire Medical Systems Revenue by Region
3 Years
5 Years
Max
Details
Inspire Medical Systems Eulerpool Fair Value
Inspire Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio
Inspire Medical Systems annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Inspire Medical Systems shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Inspire Medical Systems Earnings Estimates
Inspire Medical Systems Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/4/2026 | -0.25USD | 206.5 MUSD | 2026 Q1 |
| 2/11/2026 | 0.89USD | 270.6 MUSD | 2025 Q4 |
| 4/30/2024 | -0.51USD | 169.49 MUSD | 2024 Q1 |
| 2/5/2024 | -0.22USD | 181.5 MUSD | 2023 Q4 |
| 7/31/2023 | -0.74USD | 123.23 MUSD | 2023 Q2 |
| 5/1/2023 | -1.01USD | 102.82 MUSD | 2023 Q1 |
| 2/6/2023 | -0.69USD | 118.59 MUSD | 2022 Q4 |
| 11/1/2022 | -0.78USD | 95.73 MUSD | 2022 Q3 |
| 8/2/2022 | -0.63USD | 79.45 MUSD | 2022 Q2 |
| 5/3/2022 | -0.81USD | 65.13 MUSD | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Inspire Medical Systems stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Inspire Medical Systems shareholder structure
| % | Name |
|---|---|
12.0111% | |
11.0008% | |
8.1019% | |
6.53776% | |
5.89485% | |
5.62421% | |
3.73142% | |
3.54749% | |
2.64683% | |
2.38542% |
Inspire Medical Systems Executives and Management Board
Mr. Timothy Herbert
(62)Chairman of the Board, President, Chief Executive Officer · since 2007
Mr. Carlton Weatherby
(40)Chief Strategy and Growth Officer
Mr. Randall Ban
(60)Executive Vice President - Patient Access and Therapy Development · since 2025
Mr. Bryan Phillips
(53)Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Mr. Richard Buchholz
(57)Chief Financial Officer
Frequently asked questions about Inspire Medical Systems
The business model of Inspire Medical Systems Inc revolves around providing innovative solutions for obstructive sleep apnea (OSA) treatment. The company specializes in the development and commercialization of advanced medical devices, particularly the Inspire therapy system. This implantable device delivers mild electrical stimulation to the hypoglossal nerve, keeping the airway open during sleep and effectively reducing OSA symptoms. Through its unique business model, Inspire Medical Systems aims to improve the quality of life for individuals with sleep apnea by offering a breakthrough treatment option that can significantly alleviate symptoms and enhance overall sleep health.
Inspire Medical Systems stock
Inspire Medical Systems Peer Group
Inspire Medical Systems Ticker
Inspire Medical Systems FIGI
All fundamentals and in-depth analysis of Inspire Medical Systems
Our stock analysis for Inspire Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inspire Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.